Yingying Chen

Dr. Yingying Chen


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Theranostics
Verified
Journal Article
Open access
HLHeyangzi Li
Heyangzi Li
CWChao Wang
Chao Wang
THTeng He
Teng He
TZTengfei Zhao
Tengfei Zhao
YCYingying Chen
Yingying Chen
LWLin-Lin Wang
Lin-Lin Wang
Recent studies have demonstrated that bone marrow mesenchymal stem cells (BMSCs) protect the injured neurons of spinal cord injury (SCI) from apoptosis while the underlying mechanism of the protective effect of BMSCs remains unclear. In this study, we found the transfer of mitochondria from BMSCs to injured motor neurons and detected the functional improvement after transplanting.

1 August 2022 in Pharmacological Research
Verified
Journal Article
Closed access
NHNing He
Ning He
GSGerong Shen
Gerong Shen
XJXiaoqin Jin
Xiaoqin Jin
HLHeyangzi Li
Heyangzi Li
JWJingyu Wang
Jingyu Wang
LWLin-Lin Wang
Lin-Lin Wang

26 November 2021 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
JCJun Chen
Jun Chen
JZJinjie Zhong
Jinjie Zhong
LWLin-Lin Wang
Lin-Lin Wang
YCYingying Chen
Yingying Chen
Mitochondrial dysfunction has been proven to play a critical role in the pathogenesis of cardiovascular diseases. The phenomenon of intercellular mitochondrial transfer has been discovered in the cardiovascular system. Studies have shown that cell-to-cell mitochondrial transfer plays an essential role in regulating cardiovascular system development and maintaining normal tissue homeostasis under physiological conditions. In pathological conditions, damaged cells transfer dysfunctional mitochondria toward recipient cells to ask for help and take up exogenous functional mitochondria to alleviate injury. In this review, we summarized the mechanism of mitochondrial transfer in the cardiovascular system and outlined the fate and functional role of donor mitochondria. We also discussed the advantage and challenges of mitochondrial transfer strategies, including cell-based mitochondrial transplantation, extracellular vesicle-based mitochondrial transplantation, and naked mitochondrial transplantation, for the treatment of cardiovascular disorders. We hope this review will provide perspectives on mitochondrial-targeted therapeutics in cardiovascular diseases.

3 August 2022 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JCJun Chen
Jun Chen
CFChun-Yan Fu
Chun-Yan Fu
GSGerong Shen
Gerong Shen
JWJingyu Wang
Jingyu Wang
LXLintao Xu
Lintao Xu
LWLin-Lin Wang
Lin-Lin Wang

29 June 2021 in Cell Proliferation
Verified
Journal Article
Open access
PDF file
LXLvwan Xu
Lvwan Xu
XYXin Ye
Xin Ye
QWQingyi Wang
Qingyi Wang
BXBihan Xu
Bihan Xu
JZJinjie Zhong
Jinjie Zhong
LWLin‐Lin Wang
Lin‐Lin Wang
T cells participate in the repair process and immune response in the CNS post‐traumatic injury and play both a beneficial and harmful role. Together with nerve cells and other immune cells, they form a microenvironment in the CNS post‐traumatic injury. The repair of traumatic CNS injury is a long‐term process. T cells contribute to the repair of the injury site to influence the recovery. Recently, with the advance of new techniques, such as mass spectrometry‐based flow cytometry, modern live‐cell imaging, etc, research focusing on T cells is becoming one of the valuable directions for the future therapy of traumatic CNS injury. In this review, we summarized the infiltration, contribution and regulation of T cells in post‐traumatic injury, discussed the clinical significance and predicted the future research direction.

21 January 2022 in Journal of Advanced Research
Verified
Journal Article
Open access
JZJinjie Zhong
Jinjie Zhong
XMXingjia Mao
Xingjia Mao
HLHeyangzi Li
Heyangzi Li
GSGerong Shen
Gerong Shen
XCXi Cao
Xi Cao
YCYingying Chen
Yingying Chen
Type 1 diabetes (T1D) is a multifactorial autoimmune disease. Broad knowledge about the genetics, epidemiology and clinical management of T1D has been achieved, but understandings about the cell varieties in the bone marrow during T1D remain limited. We aimed to present a profile of the bone marrow cells and reveal the relationship of bone marrow and osteopenia in streptozotocin (STZ)-induced T1D mice. The whole bone marrow cells from the femurs and tibias of healthy (group C) and STZ-induced T1D mice (group D) were collected for single-cell RNA sequencing analysis. Single-cell flow cytometry and immunohistochemistry were performed to confirm the proportional changes among bone marrow neutrophils (BM-neutrophils) (Cxcr2+, Ly6g+) and B lymphocytes (Cd19+). X-ray and micro-CT were performed to detect bone mineral density. The correlation between the ratio of BM-neutrophils/B lymphocytes and osteopenia in STZ-induced T1D mice was analyzed by nonparametric Spearman correlation analysis. The bone marrow cells in groups C and D were divided into 12 clusters, and 249 differentially expressed genes were found. The diversity of CD45+ immune cells between groups C and D were greatly affected: the proportion of BM-neutrophils showed a significant increase while the proportion of B lymphocytes in group D showed a significant decrease. X-ray and micro-CT analyses confirmed that osteopenia occurred in group D mice. In addition, the results of single-cell flow cytometry and correlation analysis showed that the ratio of BM-neutrophils/B lymphocytes negatively correlated with osteopenia in STZ-induced T1D mice. A single-cell RNA sequencing analysis revealed the profile and heterogeneity of bone marrow immune cells in STZ-induced T1D mice for the first time. The ratio of BM-neutrophils/B lymphocytes negatively correlated with osteopenia in STZ-induced T1D mice, which may enhance understanding for treating T1D and preventing T1D-induced osteopenia.